Navigation Links
superDimension Launches Second Generation iLogic(TM)Electromagnetic Navigation Bronchoscopy System to Detect and Diagnose Lung Cancer
Date:11/2/2009

option of the system and ultimately, improve patient outcomes."

superDimension is exhibiting at the American College of Chest Physicians (CHEST) annual meeting in San Diego at booth 819 and the American Society for Radiation Oncology (ASTRO) Conference in Chicago at booth 3216.

About Lung Cancer

According to the Centers for Disease Control (CDC), "Lung cancer is the leading cause of cancer deaths in the United States, causing more deaths than breast cancer, prostate cancer and colon cancer -- the next three deadliest cancers combined. Each year, approximately 200,000 patients are newly diagnosed with lung cancer in the United States and an additional 160,000 patients die from the disease." The company notes, this is in addition to the millions of patients who are currently on watchful waiting with an undiagnosed spot on their lung.

For more information about lung cancer and its diagnosis, please visit www.spotonyourlung.com.

About superDimension

superDimension, Inc. is a Minneapolis-based, privately held company that develops and markets catheter based devices for use in the minimally invasive diagnosis and treatment of early stage lung cancer and other diseases, using the patient's natural airways to avoid surgery. For more information, please visit www.superdimension.com. 

    COMPANY CONTACTS:                          Media and Investor Contacts:
    -----------------                          ----------------------------
    superDimension, Inc.                       The Ruth Group
    Dan Sullivan                               Scott Lerman (media)
    President and CEO                          646-536-7013
    763-210-4011                               slerman@theruthgroup.
'/>"/>
SOURCE  superDimension, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 

Related medicine technology :

1. Reportlinker Adds Driving Successful Pharma Brands: Case Studies of Real Product Launches
2. Educating the Marketplace to Support Successful Oncology Product Launches
3. ViVre Medical Launches Lifesaving Medical Device
4. American College of Cardiology Launches the Nations First Registry-Based Cardiovascular Practice Network
5. WebMD Launches New Consumer Health Portal in the U.K.
6. Starch Medical Launches Novel Plant Sourced Surgical Hemostatic Pad
7. Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico
8. Prometheus Launches ProOnc Dx Cancer Diagnostics
9. Frutarom Launches New Global Branding
10. Cantel Medicals Crosstex Subsidiary Launches New Specially Treated Face Mask Effective Against H1N1 Influenza
11. Iowas Largest Health System Launches First-in-the-Nation Statewide Electronic Prescribing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... been named the 2013 Life Science Firm of the Year ... (TCM).  Vanda was honored at the TCM,s 25 th ... , Maryland.  The Tech Awards Celebration recognizes the leaders and ... Maryland and the surrounding regions. ...
(Date:5/23/2013)... May 23, 2013 Nephros, Inc. (OTC Bulletin ... device company that develops and sells high performance liquid ... rights offering.  In addition, the concurrent temporary reduction in ... on May 17, 2013. Nephros estimates that ... the rights offering.   A portion of the proceeds will ...
(Date:5/23/2013)...  Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), ... on intellectual property developed and owned by Hadassah ... medical research center, today announced that its portfolio ... from the Israeli Ministry of Industry and Commerce, ... product development and advance clinical trials. Cell Cure,s ...
Breaking Medicine Technology:Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2
... DETROIT , March 11 Caraco ... launched oxaliplatin injections. These 50mg and 100mg oxaliplatin injections, ... approval from the US Food and Drug Administration (FDA) ... is an anticancer used in the treatment of colon ...
... today the commercial launch of its new VivoTag ® 680 XL fluorescent dye for labeling biomolecules in a broad range of ... ... ... ...
Cached Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin(R) 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin(R) 3VisEn Launches New VivoTag(R) 680 XL Fluorescence Molecular Imaging Label 2VisEn Launches New VivoTag(R) 680 XL Fluorescence Molecular Imaging Label 3VisEn Launches New VivoTag(R) 680 XL Fluorescence Molecular Imaging Label 4
(Date:5/24/2013)... Texas (PRWEB) May 24, 2013 This ... 2022” provides an overview of the risk factors and ... (8MM) (US, France, Germany, Italy, Spain, UK, Australia, and ... cases of meningococcal disease segmented by age (<1, 1–4, ... (B, C, Y, and W-135) in these markets. The ...
(Date:5/24/2013)... PA (PRWEB) May 24, 2013 Patients ... be more likely to suffer from gastroesophageal reflux disease ... physicians reported in a study published today. , The ... Abnormal Proximal Exposure as Measured by Hypopharyngeal Multichannel Intraluminal ... findings could be of great importance to individuals who ...
(Date:5/24/2013)... 24, 2013 Ten Seattle’s Best Coffee ... stores were fabricated and installed over the last 3 ... Palomar Modular Buildings . , “The custom specifications for ... They made a conscious decision to utilize the modular ... with the build quality they wanted, and their plan ...
(Date:5/24/2013)... have today released updated guidelines on Hormone Replacement Therapy ... the benefits and the risks. The new guidelines appear ... published by SAGE. , Over the last 11 ... of youth" to being considered extremely risky and only ... of the Women,s Health Initiative (WHI) trial in 2002, ...
(Date:5/24/2013)... 2013 http://www.resource4thepeople.com/defectivedrugs/Zithromax-lawsuits.html , ... update involving allegations that the use of the ... allegedly cause potentially fatal irregular heart rhythms. ... 17, 2013* that Health Canada has joined the ... Zithromax can cause abnormal changes in the electrical ...
Breaking Medicine News(10 mins):Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 2Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 3Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 4Health News:West Penn Allegheny Health System Physicians Pinpoint Gastroesophageal Reflux Disease (GERD) as a Factor That May Cause Chronic Cough 2Health News:Seattle’s Best Coffee Gets Modular 2Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 2Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 3Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 4
... growing challenge, researchers say , , FRIDAY, Aug. 1 (HealthDay ... in countries with high rates of multi-drug resistant (MDR) ... Health Organization data from 2003 to 2004 for ... MDR-TB, patients are nearly twice as likely to fail ...
... WASHINGTON, August 1 Mark Merritt, President,of ... following,statement in response to new comparative effectiveness ... Committee Chair Max Baucus,(D-Mont.) and Senate Budget ... applaud Senators Baucus and Conrad for helping ...
... SAN FRANCISCO, CA The August issue of Ophthalmology, ... includes surprising findings on Asian ethnicity and macular degeneration ... a study of successful treatments for ocular surface cancer. ... Population , AMD erodes and can eventually destroy the ...
... nutritional supplement renowned for enhancing athletic performance and ... patients with chronic obstructive pulmonary disease (COPD), according ... study provided the most powerful evidence to date ... negligible at best among these patients. , "We ...
... in the document scanning industry, announced that its ... http://www.imagedocusa.com . The site introduces a ... businesses to "Go Paperless!" ImageDoc USA, headquartered ... and has created a reputation as a niche ...
... in the August 2008 edition of Otolaryngology ... medical community to develop a national consensus on ethical ... casualties of disasters such as hurricanes, tornadoes, floods, or ... Academy of Otolaryngology-Head and Neck Surgery,s Ethics Committee Chair, ...
Cached Medicine News:Health News:Drug Resistance Is Slowing Global Fight Against TB 2Health News:Highlights from the August 2008 issue of Ophthalmology 2Health News:Highlights from the August 2008 issue of Ophthalmology 3Health News:Highlights from the August 2008 issue of Ophthalmology 4Health News:No substitute for hard work: Creatine supplementation does not improve exercise outcomes in COPD 2Health News:ImageDoc USA, Inc. Launches "Go Paperless!" Website 2
... is the first truely web-based solution on the ... POC (managed from the lab) and Critical Care ... of AegisPOC ensures that all groups have the ... in the manner best suited to them. Through ...
...
... The Vari-Lase Endovenous Laser System is ... for varicose veins in the leg. Endovenous ... surgical vein-stripping for the treatment of varicose ... laser fiber is inserted into the varicosed ...
Using proven 1064 nm technology for the treatment of deeper lesions, the Lumenis One Multi-Spot Nd:YAG module provides versatility allowing targeted treatment of leg veins, vascular lesions, facial w...
Medicine Products: